Lan Huang is no stranger to awards, from being named Soroptimist International’s international-level Women’s Opportunity Award in 1997 alongside her biophysical chemistry PhD from the University of California, Berkeley, to picking up China’s Thousand Talent Innovator prize in 2009.
Her translational research in cancer signaling pathways involving Ras has been published in two papers in the scientific journal Nature and she has been hailed for her breakthrough work on ubiquitin-mediated protein degradation, a field of chemistry which won the Nobel Prize in 2004.
"I think that in the biotech business, people value you by your work"
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze